Prestige media headlines

DailyFinance - May 24, 2012 By Seth Jayson, The Motley Fool Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output.

HOUSTON, May 22, 2012 (BUSINESS WIRE) -- PLx Pharma Inc., a specialty pharmaceutical company developing a novel aspirin and lipid complex (PL2200 Aspirin 325 mg), reports that the United States Food and Drug Administration (FDA) has accepted for review ...

By Seth Jayson, The Motley Fool Prestige Brands Holdings (NYS: PBH) reported earnings on May 17. Here are the numbers you need to know. Bank of America Analysts Begin Coverage on Prestige Brands Holdings (PBH) - Junction Report Prestige Brands Holdings Rating Increased to Buy at Janney Montgomery Scott (PBH) - Movie News Guide (blog)

Junction Report - May 22, 2012 Research analysts at Bank of America (NYSE: BAC) began coverage on shares of Prestige Brands Holdings (NYSE: PBH) in a report released on Tuesday. Prestige Brands Holdings Rating Increased to Buy at Janney Montgomery Scott (PBH) - Movie News Guide (blog)

Seeking Alpha - May 18, 2012 It has been a miserable week on the street with indexes heading for their worst week since November. Although it is hard to find positives for the overall market, some individual issues have receive recent good news and are bucking the overall trend of ... Benzinga's Top Upgrades - Benzinga

NASDAQ - May 17, 2012 (RTTNews.com) - Prestige Brands Holdings Inc.'s (PBH) fourth-quarter net loss of $15000, as against a profit of $6.41 million last year. Oppenheimer Upgrades Prestige Brands Holdings to Outperform (PBH) - Junction Report Analyst Upgrades Should Help This Defensive Play Buck The Overall Market Trend - Seeking Alpha

TheStreet.com (press release) - May 4, 2012 By Business Wire 05/03/12 - 02:03 PM EDT Prestige Brands Holdings, Inc. (NYSE:PBH) today issued the following statement in response to Genomma Lab's withdrawal of its unsolicited acquisition proposal: ?Prestige has stated repeatedly that it is open to ...

Wall St. Cheat Sheet - May 3, 2012 By Mark Lawson Shares of Smith & Nephew (NYSE:SNN) rise sharply as its first quarter trading profit, boosted by knee replacements and wound care, of $252 million compared to $241 million year-to-year becomes known.

Reuters Key Development - May 3, 2012

TheStreet.com (press release) - Apr 26, 2012 By Business Wire 04/26/12 - 06:41 PM EDT Prestige Brands Holdings, Inc. (NYSE:PBH) today issued the following statement in response to Genomma Lab's comments: ?Prestige is committed to maximizing stockholder value and would be open to compelling offers ... Prestige Remains Open To Meeting With Genomma To Put Forward Compelling Offer - NASDAQ

FiercePharma Manufacturing - Apr 25, 2012 GlaxoSmithKline ($GSK) has buyers interested in taking the diet drug Alli off its hands, if Roche ($RHHBY) could just get manufacturing issues fixed so it was again available.

MedCity News - Apr 20, 2012 Brands being sold include constipation reliever Phillips Milk of Magnesia, fever and pain reliever Solpadeine and heartburn product Zantac.

BusinessWeek - Apr 20, 2012 By Stephen Gunnion on April 20, 2012 Aspen Pharmacare Holdings Ltd. (APN) gained the most in almost three years after the southern hemisphere's largest drugmaker said earnings will be boosted by the purchase of drug ranges from GlaxoSmithKline Plc.

By Seth Jayson, The Motley Fool Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output.

Prestige Brands Holdings, Inc. Completes Purchase of Debrox(EQNX::registered ... MarketWatch (press release) - Apr 2, 2012 IRVINGTON, NY, Apr 02, 2012 (BUSINESS WIRE) -- Prestige Brands Holdings, Inc. (NYSE-PBH) today announced that it has completed the purchase of the two remaining brands of the seventeen brands it agreed to acquire from GlaxoSmithKline (GSK) on December ... Prestige Brands Holdings, Inc. Completes Purchase Of Debrox? And Gly-Oxide ... - TheStreet.com (press release)